ダウンロード数: 1186
タイトル: | 膀胱癌の分子標的治療 (第56回日本泌尿器科学会中部総会) |
その他のタイトル: | Molecular targeting therapy for bladder cancer |
著者: | 東, 治人 勝岡, 洋治 |
著者名の別形: | Azuma, Haruhito Katsuoka, Yoji |
キーワード: | Locally advanced prostate cancer Treatment Surgery |
発行日: | Jan-2008 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 54 |
号: | 1 |
開始ページ: | 67 |
終了ページ: | 75 |
抄録: | Molecular-targeted drugs are agents that act on molecules which are specifically expressed in cancer, or on molecules whose expression is increased in cancer compared to normal tissue, and suppress the growth, infiltration and metastasis of cancer while affecting normal tissue as little as possible by selectively impairing function in cancer tissue. The major molecular targets in cancer therapy include oncogene products, growth factors and their receptors, signal-transducing molecules, hormone receptors, cell cycle-related proteins, telomerase-related molecules, apoptosis-related molecules, angiogenesis-related molecules, anticancer drug resistance/sensitivity factors, transcription factors, and molecules related to infiltration and metastasis. This paper reports on the molecular-targeted drugs currently considered for bladder cancer. |
URI: | http://hdl.handle.net/2433/71561 |
PubMed ID: | 18260365 |
出現コレクション: | Vol.54 No.1 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。